Qiming U.S. Ventures Management, LLC - Q4 2021 holdings

$217 Million is the total value of Qiming U.S. Ventures Management, LLC's 6 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was - .

 Value Shares↓ Weighting
NewICOSAVAX INC$80,314,0003,510,228
+100.0%
36.96%
NewJASPER THERAPEUTICS INC$45,946,0005,852,982
+100.0%
21.14%
TALS NewTALARIS THERAPEUTICS INC$44,840,0002,932,606
+100.0%
20.64%
NewVENTYX BIOSCIENCES INC$18,079,000910,306
+100.0%
8.32%
ELEV NewELEVATION ONCOLOGY INC$14,268,0002,370,142
+100.0%
6.57%
KZR NewKEZAR LIFE SCIENCES INC$13,856,000828,711
+100.0%
6.38%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ICOSAVAX INC8Q3 202337.0%
VENTYX BIOSCIENCES INC8Q3 202337.8%
TALARIS THERAPEUTICS INC8Q3 202327.1%
JASPER THERAPEUTICS INC8Q3 202321.1%
KEZAR LIFE SCIENCES INC8Q3 202312.9%
ELEVATION ONCOLOGY INC8Q3 20236.6%
HILLEVAX INC6Q3 202313.9%

View Qiming U.S. Ventures Management, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-14
13F-HR2024-02-14
13F-HR2023-11-09
13F-HR2023-07-24
13F-HR2023-04-25
13F-HR2023-01-24
13F-HR2022-11-08
13F-HR2022-07-22
13F-HR2022-05-16
13F-HR2022-02-14

View Qiming U.S. Ventures Management, LLC's complete filings history.

Export Qiming U.S. Ventures Management, LLC's holdings